Full Text
PCN112 Lessons Learned From HTA Cost Effectiveness Evaluations of New Castration-Resistant Prostate Cancer Medications

Abstract

Authors

P. Moïse P. Fassler S. Holmstrom

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×